Bristol-Myers Squibb Foundation Announces $15 Mn Expansion Of Together On Diabetes(R) To India & China

Top Quote Bristol Myers Squibb Foundation has invited partnership proposals to help bridge gaps in healthcare across geographies and disease, specifically focusing on type 2 diabetes in India End Quote
  • (1888PressRelease) May 19, 2012 - The Bristol-Myers Squibb Foundation today announced the expansion of its Together on Diabetes® initiative to India and China, pledging $15 million over five years to help these developing nations with rapidly growing numbers of type 2 diabetes patients. The International Diabetes Foundation (IDF) reports that more than 90 million people in China - 9.3 percent of the population - had type 2 diabetes in 2011, the most of any country. That figure is projected to grow to 129.7 million, or 12.1 percent of the population, by 2030.

    India, which has 61.26 million people diagnosed with type 2 diabetes (8.3 percent of the population), ranks second only to China in total cases and third behind the United States (10.9 percent) and China in terms of prevalence. By 2030, India will have 101.2 million people with type 2 diabetes, IDF projects. "In keeping with a long legacy of addressing global health issues through innovative and sustainable philanthropic programs, Bristol-Myers Squibb and the Bristol-Myers Squibb Foundation are pleased to expand our philanthropic work in type 2 diabetes to India and China, where the disease has become a significant public health concern," said Lamberto Andreotti, chief executive officer, Bristol-Myers Squibb.

    "As their populations grow older and more sedentary, health authorities in India and China are seeing many of the same problems experienced by their Western counterparts, namely obesity and type 2 diabetes," said John Damonti, president, Bristol-Myers Squibb Foundation and vice president, Corporate Philanthropy, Bristol-Myers Squibb. "What's worse, we are seeing only the tip of the iceberg. For every patient in India or China who has been diagnosed with type 2 diabetes, there are several others who are undiagnosed or considered pre-diabetic.

    Together on Diabetes is a model developed in the United States, that aims to improve health outcomes of people living with type 2 diabetes by strengthening patient self-management education, community-based supportive services and broad-based community mobilization. In line with the Bristol-Myers Squibb Foundation's mission to reduce health disparities, Together on Diabetes targets populations disproportionately affected by type 2 diabetes. After a successful launch in the United States, Bristol- Myers Squibb and the Bristol-Myers Squibb Foundation extended Together on Diabetes® to India and China to help address the growing public health issue and focus on the increased incidence of Cardiovascular/Metabolic disease in India and China through community based care and support.

    In 2012 Bristol-Myers Squibb celebrates its 125th anniversary of the company's founding; and the Bristol-Myers Squibb Foundation marks its 5th anniversary of its Delivering Hope® initiative to address hepatitis B and C in India.

  • FB Icon Twitter Icon In-Icon
Contact Information